Evidence map›Paper›PMID 24119131›Full record

ArticleJournal of thrombosis and haemostasis : JTH2013

Mechanisms of hemolysis-associated platelet activation.

C C Helms, M Marvel, W Zhao, M Stahle, R Vest, G J Kato, J S Lee, G Christ, M T Gladwin, R R Hantgan and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 182 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function.American journal of respiratory and critical care medicine · 2015
    Trial
  4. Article
  5. Article
  6. Hemocompatibility Evaluation of PEGylated Bovine Hemoglobin.International journal of molecular sciences · 2026
    Article
  7. Obesity significantly elevates thromboembolism risk in severe trauma, yet essential resuscitation with TXA and erythrocytes remains safe.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Novel compound heterozygousFrontiers in oncology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Immunoregulation role of the erythroid cells.Frontiers in immunology · 2024
    Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

C C HelmsDepartment of Physics, University of Richmond, Richmond, VA, USA.
M Marvel
W Zhao
M Stahle
R Vest
G J Kato
J S Lee
G Christ
M T Gladwin
R R Hantgan
D B Kim-Shapiro
Wake Forest University · USUniversity of Pittsburgh · USForest Institute · USUniversity of Richmond · US

Funding

Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide HomeostasisR01HL098032 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin · 2009 to 2026
$12.5M
Effects of Nitric Oxide in Sickle Cell BloodR37HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 2007 to 2016
$3.5M
Natural History of Sickle Cell Disease and Other Hemolytic DisordersZIAHL006014 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KATO, GREGORY · 2009 to 2014
$2.7M
Effects of Nitric Oxide in Sickle Cell BloodR01HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 2002 to 2006
$1.6M
MECHANISM AND KINETICS OF SICKLE CELL HEMOGLOBINR29HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 1998 to 2002
$260k
Intramural NIH HHS ZIA HL006014NHLBI NIH HHS HL058091NHLBI NIH HHS HL098032NHLBI NIH HHS R01 HL058091NHLBI NIH HHS R01 HL098032NHLBI NIH HHS R29 HL058091NHLBI NIH HHS R37 HL058091
6 · The paper itself

Abstract

backgroundIntravascular hemolysis occurs after blood transfusion, in hemolytic anemias, and in other conditions, and is associated with hypercoagulable states. Hemolysis has been shown to potently activate platelets in vitro and in vivo, and several mechanisms have been suggested to account for this, including: (i) direct activation by hemoglobin (Hb); (ii) increase in reactive oxygen species (ROS); (iii) scavenging of nitric oxide (NO) by released Hb; and (iv) release of intraerythrocytic ADP.

objectiveTo elucidate the mechanism of hemolysis-mediated platelet activation.

methodsWe used flow cytometry to detect PAC-1 binding to activated platelets for in vitro experiments, and a Siemens' Advia 120 hematology system to assess platelet aggregation by using platelet counts from in vivo experiments in a rodent model.

resultsWe found that Hb did not directly activate platelets. However, ADP bound to Hb could cause platelet activation. Furthermore, platelet activation caused by shearing of red blood cells (RBCs) was reduced in the presence of apyrase, which metabolizes ADP to AMP. The use of ROS scavengers did not affect platelet activation. We also found that cell-free Hb enhanced platelet activation by abrogating the inhibitory effect of NO on platelet activation. In vivo infusions of ADP and purified (ADP-free) Hb, as well as hemolysate, resulted in platelet aggregation, as shown by decreased platelet counts.

conclusionTwo primary mechanisms account for RBC hemolysis-associated platelet activation: ADP release, which activates platelets; and cell-free Hb release, which enhances platelet activation by lowering NO bioavailability.

Indexed as

ErythrocytesHemoglobinsHemolysisHumansIn Vitro TechniquesNitric OxidePlatelet ActivationHemoglobinsNitric Oxidehemoglobinhemolysisnitric oxideplateletsred blood cells

Identifiers

PMID24119131
PMCPMC3947421
OpenAlexW2030378408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.